ABT241018P117000
- 0.41
- -0.25-37.88%
Abbott Laboratories Newsroom
Mizuho Securities Maintains Abbott Laboratories(ABT.US) With Hold Rating, Raises Target Price to $130
Abbott Labs Price Target Raised to $130.00/Share From $115.00 by Mizuho
Abbott Labs Is Maintained at Neutral by Mizuho
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $125 to $146
Abbott Laboratories Analyst Ratings
Abbott Laboratories (ABT) Gets a Buy From Piper Sandler
Goldman Sachs Remains a Buy on Abbott Laboratories (ABT)
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT)
Morgan Stanley Adjusts Price Target on Abbott Laboratories to $117 From $107, Maintains Equalweight Rating
Abbott Laboratories: Strong Growth Prospects and Strategic Positioning Drive Buy Rating
Evercore ISI Raises Abbott Laboratories Price Target to $128 From $124
Abbott Laboratories Analyst Ratings
Raymond James Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $129
Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $127
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Buy Rating on Abbott Laboratories: Swift Clinical Advances and Strategic International Expansion
Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $127
J.P. Morgan Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $135
RBC Capital raised abbott laboratories' target price to $130.
Abbott Labs Is Maintained at Outperform by RBC Capital